As practices shift to value-based care, they need truly coordinated care teams that discuss high-risk patients and identify ways to deliver care to them, said Marcus Neubauer, MD, chief medical officer, US Oncology.
As practices shift to value-based care, they need truly coordinated care teams that discuss high-risk patients and identify ways to deliver care to them, said Marcus Neubauer, MD, chief medical officer, US Oncology.
Transcript
As more practices shift to delivering value-based care, how will their care teams change and evolve?
You said something very important: you said, “care teams.” And I think that I would emphasize that. Because cancer care clinics have always had sort of care teams—there’s a doctor, there’s a nurse, there’s somebody checking the patient in, there’s somebody who’s giving that person treatment—but that’s not a really coordinated care team. That’s just sort of a group of people, and I think that care teams are actually a really good sort of practice infrastructure that needs to be refined.
True teams that are coordinated—we use the term “team huddles,” many of our practices have adopted team huddles, where the team meets and they talk about patients who are high risk, and a physician may not know a patient is high risk, but a social worker may say, “Hey, this person has a really bad social situation,” or somebody in the financial office may say, “This patient can’t find a way to pay their copays, and that’s a stress on them.” These are things you learn in a team huddle. So, I think this is something that we need to adapt as a more uniform way that we practice. This takes time.
One thing I will say that’s positive about the Oncology Care Model is they are funding this practice transformation with these MEOS [Monthly Enhanced Oncology Services] payments. And we are using that money to try to change some of the infrastructure and workflows in our practice. But what’s nice is we’re not limiting those changes to the Medicare population. That spills over to all of our patients, because these are good advancements in patient care.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More